Based on 1 Wall Street analysts offering 12 month price targets for Innate Pharma S.A. in the last 3 months. The average price target is €3.20 with a high forecast of €3.10 and a low forecast of €3.10. The average price target represents a 84.97% change from the last price of €1.73.

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

Highest Price Target€3.10

Average Price Target€3.20

Lowest Price Target€3.10

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

IPH Analyst Recommendation Trends

Currently, no data available

Please return soon. This page is being updated.

Each month's total comprises the sum of three months' worth of ratings.

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

IPH Financial Forecast

IPH Earnings Forecast

Next quarter’s earnings estimate for IPH is -€0.26 with a range of -€0.37 to -€0.14. The previous quarter’s EPS was -€0.31. IPH beat its EPS estimate 50.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year IPH has Outperformed its overall industry.

IPH Sales Forecast

Next quarter’s sales forecast for IPH is €17.32M with a range of €9.50M to €25.14M. The previous quarter’s sales results were €8.29M. IPH beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 46.56% of the time in the same period. In the last calendar year IPH has Preformed in-line its overall industry.

IPH Stock Forecast FAQ

What is FR:IPH’s average 12-month price target, according to analysts?

Based on analyst ratings, Innate Pharma S.A.’s 12-month average price target is €3.20.

What is FR:IPH’s upside potential, based on the analysts’ average price target?

Innate Pharma S.A. has 84.97% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Innate Pharma S.A. a Buy, Sell or Hold?

Innate Pharma S.A. has a consensus rating of Hold, which is based on 0 buy ratings, 1 hold ratings and 0 sell ratings.

What is Innate Pharma S.A.’s share price target?

The average share price target for Innate Pharma S.A. is €3.20. This is based on 1 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €3.10 ,and the lowest forecast is €3.10. The average share price target represents 84.97% Increase from the current price of €1.73.

What do analysts say about Innate Pharma S.A.?

Innate Pharma S.A.’s analyst rating consensus is a Hold. This is based on the ratings of 1 Wall Streets Analysts.

How can I buy shares of Innate Pharma S.A.?

To buy shares of FR:IPH, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing